Correction: Gravina et al. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. Cancers 2022, 14, 289

Affiliations

• ¹ Department of Biotechnological and Applied Clinical Sciences, Division of Radiation Oncology, University of L'Aquila, 67100 L'Aquila, Italy.
• ² Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, 67100 L'Aquila, Italy.
• ³ Department of Biotechnological and Applied Clinical Sciences, Laboratory of Cellular Pathology, University of L'Aquila, 67100 L'Aquila, Italy.
• ⁴ Biomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, Italy.
• ⁵ Division of Pathology, San Salvatore Hospital, 67100 L'Aquila, Italy.
• ⁶ Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, 00100 Rome, Italy.
• ⁷ Department of Biotechnological and Applied Clinical Sciences, Laboratory of Medical Oncology, University of L'Aquila, 67100 L'Aquila, Italy.
• ⁸ APIM Therapeutics A/S, N-7100 Rissa, Norway.
• ⁹ Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), N-7006 Trondheim, Norway.